Suppr超能文献

2012 年在中国山东省农村地区采集的人类粪便样本中,产超广谱β-内酰胺酶大肠杆菌携带 mcr-1 黏菌素耐药基因的流行情况。

Prevalence of the mcr-1 colistin resistance gene in extended-spectrum β-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China.

机构信息

Shandong Center for Disease Control and Prevention, Jinan, Shandong, China.

Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

出版信息

Int J Antimicrob Agents. 2017 Apr;49(4):493-497. doi: 10.1016/j.ijantimicag.2016.12.018. Epub 2017 Mar 2.

Abstract

Since its initial discovery in China in 2015, the plasmid-mediated colistin resistance gene mcr-1 has been reported in Escherichia coli isolated from clinical samples, animals and meat worldwide. In this study, 706 extended-spectrum β-lactamase (ESBL)-producing E. coli from 411 persons were detected in a collection of faecal samples from 1000 rural residents in three counties in Shandong Province, China. These isolates were screened for mcr-1 and phenotypic colistin resistance. The gene was found in 3.5% of the isolates (from 4.9% of persons) from all three counties. All isolates with phenotypic colistin resistance carried mcr-1. These data indicate that commensal carriage of ESBL-producing E. coli with mcr-1 among persons in rural China was already present in 2012 and that mcr-1 was the most important colistin resistance mechanism. Interventions are necessary to minimise further dissemination of mcr-1, which would limit the future usefulness of colistin as a last-resort antibiotic.

摘要

自 2015 年在中国首次发现以来,质粒介导的粘菌素耐药基因 mcr-1 已在全球范围内从临床样本、动物和肉类中分离出的大肠杆菌中报道。本研究从山东省三个县的 1000 名农村居民的粪便样本中检测到了 706 株来自 411 人的产超广谱β-内酰胺酶(ESBL)大肠杆菌。这些分离株被筛选 mcr-1 和表型粘菌素耐药性。在来自三个县的所有分离株中,该基因的检出率为 3.5%(来自 4.9%的人)。所有表现出表型粘菌素耐药性的分离株都携带 mcr-1。这些数据表明,2012 年中国农村人群中就已经存在携带 mcr-1 的产 ESBL 大肠杆菌的共生携带,并且 mcr-1 是最重要的粘菌素耐药机制。需要采取干预措施,以尽量减少 mcr-1 的进一步传播,这将限制粘菌素作为最后手段抗生素的未来用途。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验